These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 12387068

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Treatment of high blood cholesterol in patients with coronary heart disease].
    Nagai Y, Yamashita S.
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():675-81. PubMed ID: 12735049
    [No Abstract] [Full Text] [Related]

  • 4. [Statins (HMG-CoA reductase inhibitors)].
    Gotoda T.
    Nihon Rinsho; 2006 Nov; 64(11):2113-8. PubMed ID: 17087305
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Point: Low-density lipoprotein cholesterol goals in patients with diabetes are not adequately based on evidence.
    Gosmanov AR.
    J Clin Lipidol; 2010 Nov; 4(1):69-71; discussion 74. PubMed ID: 21122629
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Treatment of high blood cholesterol in patients with coronary heart disease].
    Nagai Y, Yanagi K, Yamashita S, Takemura K, Matsuzawa Y.
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):1088-94. PubMed ID: 12436661
    [No Abstract] [Full Text] [Related]

  • 9. [Statin treatment in type 2 diabetes. Is it a must today?].
    Faust M.
    MMW Fortschr Med; 2003 Feb 27; 145(9):35-6. PubMed ID: 12666527
    [No Abstract] [Full Text] [Related]

  • 10. Updated guidelines support even lower cholesterol levels for at-risk patients.
    Levenson D.
    Rep Med Guidel Outcomes Res; 2004 Aug 06; 15(15):1, 6-7. PubMed ID: 15320342
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Eligibility for lipid-lowering drug therapy in primary prevention: how do the Adult Treatment Panel II and Adult Treatment Panel III Guidelines compare?
    Gotto AM, Kuller LH.
    Circulation; 2002 Jan 15; 105(2):136-9. PubMed ID: 11790688
    [No Abstract] [Full Text] [Related]

  • 14. [Primary and secondary prevention of coronary disease by statins].
    Ferrières J.
    Ann Cardiol Angeiol (Paris); 1999 Feb 15; 48(2):128-36. PubMed ID: 12555337
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Low-density lipoprotein cholesterol reduction and goal achievement with ezetimibe/simvastatin versus atorvastatin or rosuvastatin in patients with diabetes, metabolic syndrome, or neither disease, stratified by National Cholesterol Education Program risk category.
    Polis AB, Abate N, Catapano AL, Ballantyne CM, Davidson MH, Smugar SS, Tershakovec AM.
    Metab Syndr Relat Disord; 2009 Dec 15; 7(6):601-10. PubMed ID: 19929597
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.